This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: University of Michigan. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Maureen Legendre: Innovator in DEK Protein Inhibition
Introduction
Maureen Legendre is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of medical research, particularly in the development of treatments targeting the DEK protein. Her innovative work has the potential to impact various inflammatory and malignant diseases.
Latest Patents
Maureen Legendre holds 1 patent for her invention titled "Inhibitors of DEK protein and related methods." This patent provides methods of treatment using inhibitors of DEK protein and DEK activity. The invention includes methods for preventing, treating, and ameliorating inflammatory diseases, infections, autoimmune diseases, malignant diseases, and other conditions associated with DEK. The inhibitors include pharmaceutical compositions featuring single-stranded DNA or RNA aptamers that can bind to DEK. These aptamers are also useful for diagnosing DEK-related diseases or conditions.
Career Highlights
Maureen Legendre is affiliated with the University of Michigan, where she conducts her research and develops her innovative treatments. Her work is recognized for its potential to advance therapeutic options for patients suffering from various diseases linked to DEK.
Collaborations
Maureen collaborates with esteemed colleagues, including Nirit Mor-Vaknin and David M Markovitz. Their combined expertise enhances the research and development of effective treatments in their field.
Conclusion
Maureen Legendre's contributions to the understanding and treatment of DEK-related diseases highlight her role as an influential inventor in the medical research community. Her innovative approaches pave the way for future advancements in therapeutic interventions.